These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34762303)

  • 21. Transoral robotic surgery vs. non-robotic surgeries for oropharyngeal squamous cell carcinoma: systematic review and meta-analysis.
    Chen H; Liu Y; Huang D; Zhang X; She L
    J Robot Surg; 2023 Oct; 17(5):2537-2546. PubMed ID: 37542007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative safety and effectiveness of transoral robotic surgery versus open surgery for oropharyngeal cancer: A systematic review and meta-analysis.
    Park DA; Lee MJ; Kim SH; Lee SH
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):644-649. PubMed ID: 31627931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-utility of two minimally-invasive surgical techniques for operable oropharyngeal cancer: transoral robotic surgery versus transoral laser microsurgery.
    Parimbelli E; Soldati F; Duchoud L; Armas GL; de Almeida J; Broglie M; Quaglini S; Simon C
    BMC Health Serv Res; 2021 Oct; 21(1):1173. PubMed ID: 34711226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
    Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Patient Perspective: Evaluating the Accessibility of Transoral Robotic Surgery Online Resources.
    Xing MH; Chai RL
    Ann Otol Rhinol Laryngol; 2022 Jan; 131(1):27-38. PubMed ID: 33843290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National Analysis of Oropharyngeal Salivary Gland Malignancies Treated With Transoral Robotic Surgery.
    Bollig CA; Wang K; Llerena P; Puram SV; Pipkorn PJ; Jackson RS; Stubbs VC
    Otolaryngol Head Neck Surg; 2022 May; 166(5):886-893. PubMed ID: 34311621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feeding Tube Placement Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
    Feng AL; Holcomb AJ; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Holman A; Kammer RE; Goldsmith TA; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
    Otolaryngol Head Neck Surg; 2022 Apr; 166(4):696-703. PubMed ID: 34154449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trans oral robotic surgery for oropharyngeal cancer: A multi institutional experience.
    De Virgilio A; Pellini R; Cammaroto G; Sgarzani R; De Vito A; Gessaroli M; Costantino A; Petruzzi G; Festa BM; Campo F; Moretti C; Pichi B; Mercante G; Spriano G; Vicini C; Meccariello G
    Eur J Surg Oncol; 2023 Sep; 49(9):106945. PubMed ID: 37331862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilities.
    Janopaul-Naylor JR; Rupji M; Tobillo RA; Lorenz JW; Switchenko JM; Tian S; Kaka AS; Qian DC; Schlafstein AJ; Steuer CE; Remick JS; Rudra S; McDonald MW; Saba NF; Stokes WA; Patel MR; Bates JE
    Head Neck; 2023 Mar; 45(3):658-663. PubMed ID: 36549012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity.
    Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD;
    Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Intraoperative Frozen Section Controls With Improved Margin Assessment During Transoral Robotic Surgery for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Yu AC; Afework DD; Goldstein JD; Abemayor E; Mendelsohn AH
    JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1029-1037. PubMed ID: 36136328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
    Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary outcomes of neoadjuvant chemoimmunotherapy combined with transoral robotic surgery for locally advanced oropharyngeal squamous cell carcinoma].
    Chen RH; Liang FY; Han P; Lin PL; Lin XJ; Wang JY; Kong XW; Huang XM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):329-334. PubMed ID: 38599642
    [No Abstract]   [Full Text] [Related]  

  • 35. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).
    Haller TJ; Yin XL; O'Byrne TJ; Moore EJ; Ma DJ; Price KP; Patel SH; Hinni ML; Neben-Wittich MA; McGee LA; Price DL; Janus JR; Kasperbauer JK; Nagel TH; Routman DM; Lester SC; Rwigema JCM; Chintakuntlawar AV; Savvides PS; Garcia JJ; Foote RL; Van Abel KM
    Oral Oncol; 2023 Feb; 137():106248. PubMed ID: 36603364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
    Cracchiolo JR; Baxi SS; Morris LG; Ganly I; Patel SG; Cohen MA; Roman BR
    Cancer; 2016 May; 122(10):1523-32. PubMed ID: 26970050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.